Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study

✍ Scribed by Santiago Pavlovsky; Claudia Corrado; Miguel A. Pavlovsky; María V. Prates; Lucía Zoppegno; Mario Giunta; Ider Cerutti; Elsa Palomino; Fernando Pagani; Francisco Lastiri; Daniel Bar; Raimundo F. Bezares; Graciela Avila

• Book ID: 119936234
• Publisher: Elsevier
• Year: 2010
• Tongue: English
• Weight: 127 KB
• Volume: 10
• Category: Article
• ISSN: 2152-2650
• DOI: 10.3816/clml.2010.n.028